or Try an Advanced Search...

    Advanced Cancer Stocks List

    Symbol Grade Name % Change
    GMAB F Genmab A/S 0.90
    PBYI D Puma Biotechnology Inc 2.81
    VSTM C Verastem, Inc. -3.55
    View As Page of Charts
    Related Industries: Biotechnology Long-Term Care Facilities
    Related Stock Lists: Cancer Advanced Cancers Biotechnology Breast Cancer Medicine Non Small Cell Lung Cancer Signal Transduction Treatment Of Breast Cancer Acute Myeloid Leukemia Advanced Breast Cancer Amyloid Amyloidosis Antibodies Antibody Drug Conjugate Biopharmaceutical Breakthrough Therapy Camidanlumab Tesirine Cancer Research Cancer Stem Cell Cancer Stem Cells

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Cancer stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 3.28
    IBB D iShares Nasdaq Biotechnology Index Fund 1.61
    CNCR D Loncar Cancer Immunotherapy ETF 1.24
    WDNA D WisdomTree BioRevolution Fund 1.22
    GDOC C Goldman Sachs Future Health Care Equity ETF 0.74
    View all Advanced Cancer ETFs...
    Compare ETFs
    Compare FBT to CNCR Compare FBT to GDOC Compare FBT to WDNA

        Advanced Cancer Stocks Recent News

        Date Stock Title
        May 7 VSTM Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 GMAB Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
        May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
        May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
        May 2 GMAB Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab reports Q1 results
        May 2 GMAB Genmab Announces Financial Results for the First Quarter of 2024
        May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
        May 1 GMAB Genmab Q1 2024 Earnings Preview
        May 1 GMAB Genmab: A Complicated Tale
        Related Industries: Biotechnology Long-Term Care Facilities
        Related Stock Lists: Cancer Advanced Cancers Biotechnology Breast Cancer Medicine Non Small Cell Lung Cancer Signal Transduction Treatment Of Breast Cancer Acute Myeloid Leukemia Advanced Breast Cancer Amyloid Amyloidosis Antibodies Antibody Drug Conjugate Biopharmaceutical Breakthrough Therapy Camidanlumab Tesirine Cancer Research Cancer Stem Cell Cancer Stem Cells
        Advanced Cancer

        Advanced cancer is a term used to describe cancer that has spread from the original site to other parts of the body. It is also known as metastatic cancer. Advanced cancer is usually more difficult to treat than early-stage cancer, and the prognosis is often poorer. Treatment options may include chemotherapy, radiation therapy, and/or surgery.

        Browse All Tags